- Ticker
- AERI
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Aerie Pharmaceuticals Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers-Specialty & Generic
- Market cap
- 753.62M
- Ent value
- 1.24B
- Price/Sales
- 3.52
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 57.22%
- 3 year return
- -6.07%
- 5 year return
- -23.89%
- 10 year return
- -
Last updated: 2023-03-10
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
November 15, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
November 3, 2022
iO Charts is a Seeking Alpha partner
DIVIDENDS
AERI does not pay dividends or no data was received
Loading...
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 105.15 |
| Price to FCF | 285.79 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.52 |
| Price to Book | - |
| EV to Sales | 5.79 |
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
August 23, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
August 15, 2022
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 49.42M |
| EPS (TTM) | -0.76 |
| FCF per share (TTM) | 0.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 213.94M |
| Gross profit (TTM) | 190.42M |
| Operating income (TTM) | -26.71M |
| Net income (TTM) | -36.55M |
| EPS (TTM) | -0.76 |
| EPS (1y forward) | -1.10 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 89.01% |
| Operating margin (TTM) | -12.49% |
| Profit margin (TTM) | -17.09% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 54.09M |
| Net receivables | 73.88M |
| Total current assets | 302.81M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 375.59M |
| Accounts payable | 9.06M |
| Short/Current long term debt | 336.99M |
| Total current liabilities | 133.33M |
| Total liabilities | 539.57M |
| Shareholder's equity | -163.98M |
| Net tangible assets | -163.98M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 7.17M |
| Capital expenditures (TTM) | 4.53M |
| Free cash flow (TTM) | 2.64M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -9.73% |
| Return on Invested Capital | -23.82% |
| Cash Return on Invested Capital | 1.72% |
Loading...
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| AERI | S&P500 | |
| Current price drop from All-time high | -79.36% | -16.29% |
| Highest price drop | -93.30% | -56.47% |
| Date of highest drop | 1 Jun 2022 | 9 Mar 2009 |
| Avg drop from high | -45.85% | -11.49% |
| Avg time to new high | 27 days | 13 days |
| Max time to new high | 1096 days | 1805 days |
Aerie Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AERI) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ETCompany ParticipantsHans Vitzthum – Investor...
August 7, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
August 5, 2022
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
753.62M
Marketcap category
Small-cap
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Employees
376
Website
Investor relations
-
SEC filings
CEO
Vicente J. Anido
Country
USA
City
Durham
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
August 4, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
August 3, 2022
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
June 9, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
May 24, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AERI) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ETCompany ParticipantsHans Vitzthum – LifeSci...
May 7, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
May 5, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
May 4, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
March 18, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
February 25, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AERI) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ETCompany ParticipantsHans Vitzthum - LifeSci...
February 25, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
February 24, 2022
Get the latest news and real-time alerts from Aerie Pharmaceuticals, Inc. (AERI) stock at Seeking Alpha.
February 24, 2022
iO Charts is a Seeking Alpha partnerNext page